Response to 'Pervasive Sequence Patents Cover the Entire Human Genome'

Publication Title

Genome Medicine

Authors

Shine Tu
Yaniv Heled, Georgia State University College of LawFollow

Document Type

Article

Publication Date

1-1-2014

Abstract

In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.

Comments

External Links
SSRN

Recommended Citation

Shine Tu, et al., Response to 'Pervasive Sequence Patents Cover the Entire Human Genome', 6 Genome Med. 14 (2014).

Institutional Repository Citation

Shine Tu & Yaniv Heled, Response to 'Pervasive Sequence Patents Cover the Entire Human Genome', Faculty Publications By Year 1213 (2014)
https://readingroom.law.gsu.edu/faculty_pub/1213

DOI

10.1186/gm531

Volume

6

Issue

2

First Page

14

Last Page

14